Optic atrophy: genes and variants

Optic atrophy is linked to 4 analyzed proteins (OPA1, ABCA4, ABCC6 and WDR45). 10 DNA variants are known to cause it; 17 more are uncertain, and 0 of those already look disease-causing on computable evidence.

Last updated 2026-09-30. Research information, not medical advice.

Also known as: optic atrophy 2

Genes linked to Optic atrophy

Weakly linked (only a few uncertain records): CRB1, MFN2, CEP290, EYS, IFT172, ISCA2, PROS1 and WDR19.

Where Optic atrophy variants cluster

Known disease-causing variants in Optic atrophy

VariantPositionProtein partClinical label
ABCA4 T959A959ABC transporter 1Disease-causing (★★)
OPA1 S545R545Dynamin-type GDisease-causing (★★)
ABCC6 M751K751ABC transporter 1Disease-causing (★★)
OPA1 S422R422Dynamin-type GDisease-causing (★★)
OPA1 P400A400Dynamin-type GDisease-causing
WDR45 P36H36Disease-causing
OPA1 D273A273Mitochondrial intermembraneDisease-causing
OPA1 G459E459Dynamin-type GDisease-causing
OPA1 G768D768Paddle regionDisease-causing
OPA1 L939P939Coiled coilDisease-causing

Same protein, different disease

Diseases related to Optic atrophy

Frequently asked questions

Which genes are linked to Optic atrophy?

In CATVariant, Optic atrophy is linked to 4 analyzed proteins: OPA1 (Dynamin-like GTPase OPA1, mitochondrial), ABCA4 (Retinal-specific phospholipid-transporting ATPase ABCA4), ABCC6 (ATP-binding cassette sub-family C member 6) and WDR45 (WD repeat domain phosphoinositide-interacting protein 4).

How many genetic variants are linked to Optic atrophy?

35 variants: 10 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 17 are of uncertain significance or have conflicting reports.

Which uncertain variants in Optic atrophy look disease-causing?

None of the uncertain variants currently reaches the likely-pathogenic range on computable evidence alone.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center